| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |